These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 11592233)

  • 1. Nicotine affects the signaling of the death pathway, reducing the response of head and neck cancer cell lines to DNA damaging agents.
    Onoda N; Nehmi A; Weiner D; Mujumdar S; Christen R; Los G
    Head Neck; 2001 Oct; 23(10):860-70. PubMed ID: 11592233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitation of the change in GADD153 messenger RNA level as a molecular marker of tumor response in head and neck cancer.
    Los G; Benbatoul K; Gately DP; Barton R; Christen R; Robbins KT; Vicario D; Kirmani S; Orloff LA; Weisman R; Howell SB
    Clin Cancer Res; 1999 Jul; 5(7):1610-8. PubMed ID: 10430059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA damage inducible-gene expression following platinum treatment in human ovarian carcinoma cell lines.
    Delmastro DA; Li J; Vaisman A; Solle M; Chaney SG
    Cancer Chemother Pharmacol; 1997; 39(3):245-53. PubMed ID: 8996528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cisplatin and taxol activate different signal pathways regulating cellular injury-induced expression of GADD153.
    Gately DP; Sharma A; Christen RD; Howell SB
    Br J Cancer; 1996 Jan; 73(1):18-23. PubMed ID: 8554977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative effects on c-Jun N-terminal protein kinase signaling determine synergistic interaction of cisplatin and 17-allylamino-17-demethoxygeldanamycin in colon cancer cell lines.
    Vasilevskaya IA; Rakitina TV; O'Dwyer PJ
    Mol Pharmacol; 2004 Jan; 65(1):235-43. PubMed ID: 14722256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantification of tumor cell injury in vitro and in vivo using expression of green fluorescent protein under the control of the GADD153 promoter.
    Lin X; Gately DP; Hom D; Mishima M; Los G; Howell SB
    Int J Cancer; 2001 Feb; 91(4):555-62. PubMed ID: 11251981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cisplatin-induced activation of mitogen-activated protein kinases in ovarian carcinoma cells: inhibition of extracellular signal-regulated kinase activity increases sensitivity to cisplatin.
    Persons DL; Yazlovitskaya EM; Cui W; Pelling JC
    Clin Cancer Res; 1999 May; 5(5):1007-14. PubMed ID: 10353733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synergistic induction of tumor cell apoptosis by death receptor antibody and chemotherapy agent through JNK/p38 and mitochondrial death pathway.
    Ohtsuka T; Buchsbaum D; Oliver P; Makhija S; Kimberly R; Zhou T
    Oncogene; 2003 Apr; 22(13):2034-44. PubMed ID: 12673208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term activation of SAPK/JNK, p38 kinase and fas-L expression by cisplatin is attenuated in human carcinoma cells that acquired drug resistance.
    Brozovic A; Fritz G; Christmann M; Zisowsky J; Jaehde U; Osmak M; Kaina B
    Int J Cancer; 2004 Dec; 112(6):974-85. PubMed ID: 15386344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of tumor progression via the Snail-RKIP signaling pathway by nicotine exposure in head and neck squamous cell carcinoma.
    Nieh S; Jao SW; Yang CY; Lin YS; Tseng YH; Liu CL; Lee TY; Liu TY; Chu YH; Chen SF
    Head Neck; 2015 Dec; 37(12):1712-21. PubMed ID: 24986226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Electronic cigarettes induce DNA strand breaks and cell death independently of nicotine in cell lines.
    Yu V; Rahimy M; Korrapati A; Xuan Y; Zou AE; Krishnan AR; Tsui T; Aguilera JA; Advani S; Crotty Alexander LE; Brumund KT; Wang-Rodriguez J; Ongkeko WM
    Oral Oncol; 2016 Jan; 52():58-65. PubMed ID: 26547127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MEK inhibition enhances bleomycin A5-induced apoptosis in an oral cancer cell line: signaling mechanisms and therapeutic opportunities.
    Yang LC; Yang SH; Tai KW; Chou MY; Yang JJ
    J Oral Pathol Med; 2004 Jan; 33(1):37-45. PubMed ID: 14675139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Introduction of gadd153 gene into gastric cancer cells can modulate sensitivity to anticancer agents in association with apoptosis.
    Kim R; Ohi Y; Inoue H; Aogi K; Toge T
    Anticancer Res; 1999; 19(3A):1779-83. PubMed ID: 10470115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Roles of JNK, p38 and ERK mitogen-activated protein kinases in the growth inhibition and apoptosis induced by cadmium.
    Chuang SM; Wang IC; Yang JL
    Carcinogenesis; 2000 Jul; 21(7):1423-32. PubMed ID: 10874022
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acetaminophen induces apoptosis of C6 glioma cells by activating the c-Jun NH(2)-terminal protein kinase-related cell death pathway.
    Bae MA; Pie JE; Song BJ
    Mol Pharmacol; 2001 Oct; 60(4):847-56. PubMed ID: 11562448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Grape seed extract inhibits EGF-induced and constitutively active mitogenic signaling but activates JNK in human prostate carcinoma DU145 cells: possible role in antiproliferation and apoptosis.
    Tyagi A; Agarwal R; Agarwal C
    Oncogene; 2003 Mar; 22(9):1302-16. PubMed ID: 12618755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. C-Jun N-terminal kinase signalling pathway in response to cisplatin.
    Yan D; An G; Kuo MT
    J Cell Mol Med; 2016 Nov; 20(11):2013-2019. PubMed ID: 27374471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between hsp60 messenger-RNA levels and Cisplatin resistance in human head and neck-cancer cell-lines.
    Nakata B; Barton R; Robbins K; Howell S; Los G
    Int J Oncol; 1994 Dec; 5(6):1425-32. PubMed ID: 21559731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of JNK and c-Abl signalling by cisplatin and oxaliplatin in mismatch repair-proficient and -deficient cells.
    Nehmé A; Baskaran R; Nebel S; Fink D; Howell SB; Wang JY; Christen RD
    Br J Cancer; 1999 Mar; 79(7-8):1104-10. PubMed ID: 10098743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An anti-GD2 monoclonal antibody enhances apoptotic effects of anti-cancer drugs against small cell lung cancer cells via JNK (c-Jun terminal kinase) activation.
    Yoshida S; Kawaguchi H; Sato S; Ueda R; Furukawa K
    Jpn J Cancer Res; 2002 Jul; 93(7):816-24. PubMed ID: 12149148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.